Target intelligence / Profile preview

RNA, U1 small nuclear 76, pseudogene (RNU1-76P)

Target
RNU1-76P
Molecular classification
Other, Pseudogene, Small nuclear RNA (snRNA) pseudogene
01

Overview

RNA, U1 small nuclear 76, pseudogene (RNU1-76P) is a member of the U1 small nuclear RNA pseudogene family. Pseudogenes are genomic DNA sequences similar to normal genes but are typically non-functional due to mutations or lack of regulatory elements, and do not encode functional products[5][4][6]. RNU1-76P is specifically annotated as a pseudogene for U1 small nuclear RNA, which, in its functional (non-pseudogene) forms, plays an essential role in spliceosome assembly and the splicing of pre-mRNA. However, RNU1-76P itself is not known to be transcribed into a functional RNA, and there is no evidence it acts as a receptor, enzyme, transporter, or therapeutic target. Therefore, it is not considered a drug target or relevant for biomarker development or disease association[5][4][6]. The gene is present in genome annotations (e.g., as HGNC:48418, Ensembl: ENSG00000199773, NCBI Gene: 106481617), but is mostly listed for reference and not for active biological or clinical roles[5].\n\nKey points:\n- This gene is a **pseudogene**—it does not code for a functional molecule[5][4][6].\n- It is not considered a **therapeutic target** because pseudogenes, by definition, lack function.\n- There are no known biological functions, disease associations, or drug interactions related to RNU1-76P[5][4][6].\n- Its only common alias is RNU1-76P.\n- Its family (U1 snRNA or small nuclear RNA) is important for mRNA splicing, but this pseudogene does not participate in these activities.\n\nThere is nothing misspelled in the target’s name, but the **inquiry as a therapeutic target is incorrect**, as pseudogenes are not molecular targets for therapeutic intervention[5][4][6].

Other names
RNU1-76P

Beyond the preview

Go deeper on RNA, U1 small nuclear 76, pseudogene (RNU1-76P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U1 small nuclear 76, pseudogene (RNU1-76P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call